TY - JOUR
T1 - Impact of race on the association of mineral metabolism with heart failure
T2 - The multi-ethnic study of atherosclerosis
AU - Robinson-Cohen, Cassianne
AU - Shlipak, Michael
AU - Sarnak, Mark
AU - Katz, Ronit
AU - Peralta, Carmen
AU - Young, Bessie
AU - Hoofnagle, Andrew N.
AU - Szklo, Moyses
AU - Ix, Joachim H.
AU - Psaty, Bruce M.
AU - de Boer, Ian H.
AU - Kestenbaum, Bryan
AU - Bansal, Nisha
N1 - Funding Information:
This work was supported by the National Heart, Lung, and Blood Institute (Contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, and N01-HC-95169), the National Center for Advancing Translational Sciences (Grant UL1-TR-000040, Grant UL1-TR-001079, and Grant UL1-TR-001420), and the National Institute of Diabetes and Digestive and Kidney Diseases (Grant R01DK088762), (Grant R01DK099199), and Grant (K01DK109019).
Publisher Copyright:
© Endocrine Society 2019. All rights reserved.
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Background: Alterations in mineral metabolism, such as high phosphorus, high parathyroid hormone (PTH), and high fibroblast growth factor-23 (FGF-23) have been identified as potential risk factors for heart failure (HF). Important differences in the prevalence of mineral metabolism abnormalities and in the risk of HF have been reported across race and/or ethnic groups. In this study, we evaluated whether the associations of mineral metabolism markers with HF differed by race and/or ethnicity. Methods: We included participants free of cardiovascular disease from the Multi-Ethnic Study of Atherosclerosis to quantify rates of HF overall and across race and/or ethnic groups. Using Cox models, we tested associations of baseline higher phosphorus (>4 mg/dL), PTH greater than 65 pg/mL, and FGF-23 greater than 46.5 pg/mL with incident HF, and for interactions by race and/or ethnicity, adjusting for sociodemographic and cardiovascular risk factors. Results: Among the 6413 participants, median follow-up time was 14.9 years. The incidence rate for HF was highest for African Americans and lowest for Chinese (4.71 and 2.42 per 1000 person-years, respectively). The prevalence of elevated PTH (18.8% vs 7.4%) but not FGF-23 (23.1% vs 28.8%) was higher in African Americans vs Whites. In multivariable models, the associations of elevated PTH (hazard ratio [HR] 1.50, 95% CI: 1.13-1.99) and FGF-23 (HR 1.37, 95% CI: 1.07-1.75) with incident HF were statistically significant. However, the interactions by race and/or ethnicity were not statistically significant. Conclusions: In a multiethnic population, higher PTH and FGF-23 were associated with risk of HF in African American and Hispanic individuals. There is no evidence that race and/or ethnicity modifies the association of altered mineral metabolism with risk of HF.
AB - Background: Alterations in mineral metabolism, such as high phosphorus, high parathyroid hormone (PTH), and high fibroblast growth factor-23 (FGF-23) have been identified as potential risk factors for heart failure (HF). Important differences in the prevalence of mineral metabolism abnormalities and in the risk of HF have been reported across race and/or ethnic groups. In this study, we evaluated whether the associations of mineral metabolism markers with HF differed by race and/or ethnicity. Methods: We included participants free of cardiovascular disease from the Multi-Ethnic Study of Atherosclerosis to quantify rates of HF overall and across race and/or ethnic groups. Using Cox models, we tested associations of baseline higher phosphorus (>4 mg/dL), PTH greater than 65 pg/mL, and FGF-23 greater than 46.5 pg/mL with incident HF, and for interactions by race and/or ethnicity, adjusting for sociodemographic and cardiovascular risk factors. Results: Among the 6413 participants, median follow-up time was 14.9 years. The incidence rate for HF was highest for African Americans and lowest for Chinese (4.71 and 2.42 per 1000 person-years, respectively). The prevalence of elevated PTH (18.8% vs 7.4%) but not FGF-23 (23.1% vs 28.8%) was higher in African Americans vs Whites. In multivariable models, the associations of elevated PTH (hazard ratio [HR] 1.50, 95% CI: 1.13-1.99) and FGF-23 (HR 1.37, 95% CI: 1.07-1.75) with incident HF were statistically significant. However, the interactions by race and/or ethnicity were not statistically significant. Conclusions: In a multiethnic population, higher PTH and FGF-23 were associated with risk of HF in African American and Hispanic individuals. There is no evidence that race and/or ethnicity modifies the association of altered mineral metabolism with risk of HF.
KW - Fibroblast growth factor-23
KW - Heart failure
KW - Mineral metabolism
KW - Parathyroid hormone
KW - Phosphorus
UR - http://www.scopus.com/inward/record.url?scp=85081944006&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081944006&partnerID=8YFLogxK
U2 - 10.1210/clinem/dgz218
DO - 10.1210/clinem/dgz218
M3 - Article
C2 - 31760429
AN - SCOPUS:85081944006
SN - 0021-972X
VL - 105
SP - E1144-E1151
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 4
ER -